Literature DB >> 2360460

Acute surgery in intracranial aneurysms. Experience with 100 cases.

J Bidziński1, A Marchel, M Pastuszko.   

Abstract

In the last 3.5 years (up to August 1988) out of 450 patients with surgically treated intracranial aneurysms in 100 cases (22%) acute surgery was performed (up to 72 h after SAH). Patients in grade I-III (WFNS scale) were operated upon. In all the cases there were supratentorial aneurysms. CSF drainage during the operation was used routinely and nimodipine topically, in intravenous infusion and orally was applied. In all the cases, but one, the aneurysms was clipped. Follow-up--1 year. Assessment of the results was done using the Glasgow Outcome Scale (GOS). Full recovery was obtained in 78 patients and further 5 patients are independent. There were 14 deaths, in 7 patients due to postoperative vasospasm. Symptomatic ischaemia developed in 25 patients, however, in 15 of them it was fully reversible, due to the possibility of aggressive antivasospastic treatment (hypervolaemia, induced arterial hypertension). The relatively worse results were obtained in patients with chronic arterial hypertension.

Entities:  

Mesh:

Year:  1990        PMID: 2360460     DOI: 10.1007/bf01420184

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  The value of computerized tomography in aneurysmal subarachnoid hemorrhage. The concept of the CT score.

Authors:  N T Gurusinghe; A E Richardson
Journal:  J Neurosurg       Date:  1984-04       Impact factor: 5.115

2.  Timing of aneurysm surgery.

Authors:  N F Kassell; C G Drake
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

3.  Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.

Authors:  J Philippon; R Grob; F Dagreou; M Guggiari; M Rivierez; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

4.  Early operation and overall outcome in aneurysmal subarachnoid hemorrhage.

Authors:  B Ljunggren; H Säveland; L Brandt; S Zygmunt
Journal:  J Neurosurg       Date:  1985-04       Impact factor: 5.115

5.  Management mortality and the timing of surgery for supratentorial aneurysm.

Authors:  B Weir; K Aronyk
Journal:  J Neurosurg       Date:  1981-02       Impact factor: 5.115

6.  Early aneurysm operation and outcome in two remote Scandinavian populations.

Authors:  M Vapalahti; B Ljunggren; H Säveland; J Hernesniemi; L Brandt; A Tapaninaho
Journal:  J Neurosurg       Date:  1984-06       Impact factor: 5.115

7.  Prevention of vasospasm by early operation with removal of subarachnoid blood.

Authors:  M Mizukami; T Kawase; T Usami; T Tazawa
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

8.  Results and complications of surgical management of 809 intracranial aneurysms in 722 cases. Related and unrelated to grade of patient, type of aneurysm, and timing of surgery.

Authors:  T M Sundt; S Kobayashi; N C Fode; J P Whisnant
Journal:  J Neurosurg       Date:  1982-06       Impact factor: 5.115

9.  Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms.

Authors:  L M Auer
Journal:  Neurosurgery       Date:  1984-07       Impact factor: 4.654

10.  Results of early operations for ruptured aneurysms.

Authors:  B Ljunggren; L Brandt; E Kågström; G Sundbärg
Journal:  J Neurosurg       Date:  1981-04       Impact factor: 5.115

View more
  3 in total

1.  Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.

Authors:  F Porchet; R Chioléro; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Formation of new aneurysms. Report of five cases.

Authors:  A Marchel; J Bidziński; P Bojarski
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.

Authors:  M Ryba; P Grieb; M Pastuszko; J Bidziński; J Andrychowski; C Dziewiecki; P Bojarski; L Królicki
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.